Related Experiment Videos

Effects of simvastatin on pro-inflammatory cytokines in patients with hypercholesterolemia

Barbara Zubelewicz-Szkodzińska1, Janusz Szkodziński, Aleksander Danikiewicz

  • 1Department of Internal Diseases, Silesian Medical Academy, Bytom, Poland.

Kardiologia Polska
|January 16, 2004
PubMed

Insights

Simvastatin significantly reduced interleukin-2 (IL-2) levels in hypercholesterolemia patients, while diet alone decreased tumor necrosis factor-alpha (TNFalpha). Simvastatin further reduced IL-2 but not TNFalpha post-diet.

Area of Science:

  • Cardiology
  • Immunology
  • Pharmacology

Background:

  • Inflammation plays a key role in atherosclerosis development.
  • Pro-inflammatory cytokines are implicated in cardiovascular disease.
  • Cytokine imbalance may contribute to myocardial ischemia.

Purpose of the Study:

  • To evaluate the impact of simvastatin on interleukin-2 (IL-2) and tumor necrosis factor-alpha (TNFalpha) levels.
  • To assess the effects of simvastatin in patients with hypercholesterolemia.

Main Methods:

  • A study involving 64 males with hypercholesterolemia and 10 healthy controls.
  • Measurements of lipids, IL-2, and TNFalpha at baseline, after diet, and after simvastatin therapy.
  • Comparison of cytokine levels between hypercholesterolemic patients and healthy individuals.

Main Results:

  • Simvastatin significantly reduced total and LDL-cholesterol.
  • Simvastatin therapy led to a significant decrease in IL-2 plasma concentration.
  • Diet significantly decreased TNFalpha serum concentration, with a non-significant further reduction by simvastatin.

Conclusions:

  • A hypolipemic diet effectively lowers TNFalpha but does not impact IL-2 levels.
  • Simvastatin therapy significantly reduces IL-2 levels compared to post-diet values.
  • Simvastatin did not significantly alter TNFalpha levels beyond the effects of diet.
Abstract

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Inflammation01:38

Inflammation

Overview
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...